Minor Antigen Distribution Predicts Site-Specific Graft-versus-Tumor Activity of Adoptively Transferred, Minor Antigen-Specific CD8 T Cells

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 1, 2014, Pages 26-36

  Shand, Jessica C ^a,c   Qin, Haiying ^a   Nasholm, Nicole ^a   Capitini, Christian M ^b   Fry, Terry J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Acute lymphoblastic leukemia; Adoptive T cell therapy; Allogeneic transplantation; CD8T cell function; Minor histocompatibility antigens

Indexed keywords

ALLOANTIGEN; DENDRITIC CELL VACCINE; GAMMA INTERFERON; HY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE T LYMPHOCYTE THERAPY; ADOPTIVE TRANSFER; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LEUKEMIA; CANCER CONTROL; CD8+ T LYMPHOCYTE; CELL THERAPY; CONTROLLED STUDY; DENDRITIC CELL; EPITHELIUM TUMOR; EX VIVO STUDY; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC TISSUE; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; SOLID TUMOR; TUMOR GROWTH;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOPTIVE T CELL THERAPY; ALLOGENEIC TRANSPLANTATION; CD8 T CELL FUNCTION; MINOR HISTOCOMPATIBILITY ANTIGENS;

ADOPTIVE TRANSFER; ALLELES; ANIMALS; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; H-Y ANTIGEN; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, TRANSGENIC; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELLS, B-LYMPHOID; SURVIVAL ANALYSIS;

EID: 84890937525     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.10.009     Document Type: Article

References (40)

1. Miller J.S., Warren E.H., van den Brink M.R., et al. NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Biology Underlying Recurrence of Disease following Allogeneic HSCT. Biol Blood Marrow Transplant 2010, 16:565-586.
2. Kolb H.J. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 2008, 112:4371-4383.
3. Warlick E.D., DeFor T., Blazar B.R., et al. Successful remission rate and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012, 18:480-486.
4. Barrett D., Fish J.D., Grupp S.A. Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors. Pediatr Clin North Am 2010, 57:47-66.
5. Matte-Martone C., Venkatesan S., Tan H.S., et al. Graft-versus-leukemia (GVL) against mouse blast-crisis chronic myelogenous leukemia (BCML) and chronic-phase chronic myelogenous leukemia (CP-CML): shared mechanisms of T cell killing but programmed death ligands render CP-CML, and not BC-CML GVL resistant. JImmunol 2011, 15:1653-1663.
6. Horowitz M.M., Gale R.P., Sondel P.M., et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990, 75:555-562.
7. Feng X., Kwok M.H., Younes H., Brickner A.G. Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses. Trends Immunol 2008, 29:624-632.
8. Meunier M.C., Delisle J.S., Bergeron J., et al. Tcells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat Med 2005, 11:1222-1229.
9. Fontaine P., Roy-Proulx G., Knafo L., et al. Adoptive transfer of minor histocompatibility antigen-specific T lymphocyte eradicates leukemia cells without causing graft-versus-host disease. Nat Med 2001, 7:789-794.
10. Li N., Matte-Martone C., Zheng H., et al. Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution. Blood 2011, 118:5965-5976.
11. Meunier M.C., Roy-Proulx G., Labrecque N., Perreault C. Tissue distribution of target antigen has a decisive influence on the outcome of adoptive cancer immunotherapy. Blood 2003, 101:766-770.
12. Zuniga E.I., Harker J.A. Tcell exhaustion due to persistent antigen: quantity not quality?. Eur J Immunol 2012, 42:2285-2289.
13. Flutter B., Edwards N., Fallah-Arani F., et al. Nonhematopoietic antigen blocks memory programming of alloreactive CD8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation. JClin Invest 2010, 120:3855-3868.
14. Asakura S., Hashimoto D., Takashima S., et al. Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice. JClin Invest 2010, 120:2370-2378.
15. Zhou Q., Munger M.R., Veenstra R.G., et al. Coexpression of Tim-3 and PD-1 identifies a CD8+ T cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood 2011, 117:4501-4510.
16. Kim Y.H., Faaij C.M., van Halteren A.G., et al. In situ detection of HY-specific T cells in acute graft-versus-host disease-affected male skin after sex-mismatched stem cell transplantation. Biol Blood Marrow Transplant 2012, 18:381-387.
17. Randolph S.S., Gooley T.A., Warren E.H., et al. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplant. Blood 2004, 103:347-352.
18. Valjuskikh A., Lantz O., Celli S., et al. Cross-primed CD8(+) T-cells mediate graft rejection via a distinct effector pathway. Nat Immunol 2002, 3:844-851.
19. Cooke K.R., Kozbik L., Martin T.R., et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996, 88:3230-3239.
20. Capitini C.M., Nasholm N.M., Duncan B.B., et al. Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis. JImmunol 2013, 190:1351-1359.
21. Lu Y.F., Gavrilescu L.C., Betancur M., et al. Distinct graft-versus-leukemic stem cell effects of early or delayed donor leukocyte infusions in a mouse chronic myeloid leukemia model. Blood 2012, 119:273-284.
22. Fry T., Shand J., Milliron M., et al. Antigen loading of DCs with irradiated apoptotic tumor cells induces improved antitumor immunity compared with other approaches. Cancer Immunol Immunother 2009, 58:1257-1264.
23. Melchionda F., Fry T.J., Milliron M.J., et al. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. JClin Invest 2005, 115:1177-1187.
24. Bijl J., Savageau M., Thompson A., Savageau G. High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia. Genes Dev 2005, 19:224-233.
25. Toubai T., Tawara I., Sun Y., et al. Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen presenting cells. Blood 2012, 119:3844-3853.
26. Capitini C.M., Herby S., Milliron M., et al. Bone marrow deficient in IFN-y selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect. Blood 2009, 113:5002-5009.
27. Reddy P., Negrin R., Hill G.R. Mouse models of bone marrow transplantation. Biol Blood Marrow Transplant 2008, 14:129-135. Erratum in: Biol Blood Marrow Transplant 2008;14: 1317-1318.
28. Melchionda F., McKirdy M.K., Medeiros P., et al. Escape from immune surveillance does not result in tolerance to tumor-associated antigens. JImmunother 2004, 27:329-338.
29. Norde W.J., Hobo W., van der Voort R., Dolstra H. Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention. Blood 2012, 120:728-736.
30. Hobo W., Broen K., van der Velden W.J., et al. Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2013, 19:274-282.
31. Perreault C. In search of immunodominant minor histocompatibility antigens. Biol Blood Marrow Transplant 2013, 19:171-172.
32. Velu V., Kannanganat S., Ibegbu C., et al. Elevated expression levels of inhibitory receptor programmed death-1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination. JVirol 2007, 81:5819-5828.
33. Richter K., Brocker T., Oxenius A. Antigen amount dictates CD8(+) T cell exhaustion during chronic viral infection irrespective of the type of antigen presenting cell. Eur J Immunol 2012, 42:2290-2304.
34. Ahmed R. Restoring function in exhausted CD8 T-cells during chronic viral infection. Nature 2006, 439:682-687.
35. Wang X.N., Haniffa M.A., Holtick U., et al. Regulatory T cell suppression of CD8+ T cell mediated graft-versus-host reaction requires their presence during priming. Transplantation 2009, 88:188-197.
36. Warren E.H., Fujii N., Akatsuka Y., et al. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T-cells specific for minor histocompatibility antigens. Blood 2010, 115:3869-3878.
37. Hokey D.A., Johnson B.F., Smith J., et al. Activation drives PD-1 expression during vaccine-specific proliferation following lentivirus infection in macaques. Eur J Immunol 2008, 38:1435-1445.
38. Brown K.E., Freeman G.J., Wherry E.J., Sharpe A.H. Role of PD-1 in regulating acute infections. Curr Opin Immunol 2010, 22:397-401.
39. Juchem W.K., Anderson B.E., Zhang E., et al. Arepertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells. Blood 2011, 118:6209-6219.
40. Norde W.J., Maas F., Hobo W., et al. PD-1/PDL-1 interactions contribute to functional T cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation. Cancer Res 2011, 71:5111-5122.